BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24259030)

  • 21. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
    Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
    Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience.
    Pierorazio PM; Gorin MA; Ross AE; Feng Z; Trock BJ; Schaeffer EM; Han M; Epstein JI; Partin AW; Walsh PC; Bivalacqua TJ
    Prostate; 2013 Nov; 73(15):1673-80. PubMed ID: 24019101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the One-Step Nucleic Acid Amplification method of lymph nodes examination make the staging of pulmonary tumours more precise?
    Vodička J; Vejvodová Š; Pešta M; Mukenšnabl P; Špidlen V; Kulda V; Houfková K; Topolčan O
    Rozhl Chir; 2018; 97(8):373-378. PubMed ID: 30441990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer.
    Gonzalez Bosquet J; Keeney GL; Mariani A; Webb MJ; Cliby WA
    Gynecol Oncol; 2003 Dec; 91(3):518-25. PubMed ID: 14675670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
    Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
    BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of the histologically and immunohistochemically detected solitary lymph node metastases in gastric cancer.
    Griniatsos J; Yiannakopoulou E; Gakiopoulou H; Alexandrou A; Dimitriou N; Karavokyros I; Felekouras E
    Scand J Surg; 2011; 100(3):174-80. PubMed ID: 22108745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal lymph node step-sectioning for the identification of metastatic disease in canine mast cell tumor.
    Sabattini S; Faroni E; Renzi A; Ghisoni G; Rigillo A; Bettini G; Pasquini A; Zanardi S; Guerra D; Marconato L
    Vet Pathol; 2022 Sep; 59(5):768-772. PubMed ID: 35400236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
    Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
    Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of
    Zhang Q; Zang S; Zhang C; Fu Y; Lv X; Zhang Q; Deng Y; Zhang C; Luo R; Zhao X; Wang W; Wang F; Guo H
    J Transl Med; 2017 Nov; 15(1):230. PubMed ID: 29115970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detecting metastatic prostate carcinoma in pelvic lymph nodes following neoadjuvant hormone therapy: the eyes have it!
    Kehr E; Masry P; Lis R; Loda M; Taplin ME; Hirsch MS
    Histopathology; 2016 Jan; 68(2):303-7. PubMed ID: 26018610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series.
    Ball MW; Harris KT; Schwen ZR; Mullins JK; Han M; Walsh PC; Partin AW; Epstein JI
    BJU Int; 2017 Mar; 119(3):444-448. PubMed ID: 27611825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of occult lymph-node metastasis missed by standard pathological examination in patients with bladder cancer undergoing radical cystectomy.
    Jensen JB; Høyer S; Jensen KM
    Scand J Urol Nephrol; 2011 Dec; 45(6):419-24. PubMed ID: 21767245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
    Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
    Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved detection of metastases by step sectioning and immuno-histochemical staining of axillary sentinel nodes in patients with breast carcinoma.
    Ensani F; Enayati L; Rajabiani A; Omranipour R; Alavi N; Mosahebi S
    Asian Pac J Cancer Prev; 2013; 14(10):5731-4. PubMed ID: 24289570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.
    Passoni NM; Fajkovic H; Xylinas E; Kluth L; Seitz C; Robinson BD; Rouprêt M; Chun FK; Lotan Y; Roehrborn CG; Crivelli JJ; Karakiewicz PI; Scherr DS; Rink M; Graefen M; Schramek P; Briganti A; Montorsi F; Tewari A; Shariat SF
    BJU Int; 2014 Oct; 114(4):503-10. PubMed ID: 24053552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intermediate and high risk prostate cancer patients. Clinical significance of extended lymphadenectomy].
    Osmonov DK; Boller A; Aksenov A; Naumann M; Jünemann KP
    Urologe A; 2013 Feb; 52(2):240-5. PubMed ID: 23150089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of multisection and immunohistochemistry in lymph node staging of Gastric Carcinoma - Case series.
    Santos FAV; Drummond-Lage AP; Wainstein AJA; Dias-Filho MA; Savassi-Rocha PR; Navarro TP
    Sci Rep; 2020 Feb; 10(1):3271. PubMed ID: 32094351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement.
    Isebaert S; Haustermans K; Van den Bergh L; Joniau S; Dirix P; Oyen R; Deroose CM; Van Poppel H; Lerut E
    Acta Oncol; 2013 Oct; 52(7):1336-44. PubMed ID: 23879650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy.
    Clobes H; Fossâ SD; Waehre H; Jocham D; Berner A
    BJU Int; 2000 Feb; 85(3):270-5. PubMed ID: 10671880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.